University of Iowa Health Care patients are the first in the nation to have access to a new technology that uses artificial intelligence to diagnose diabetic retinopathy. The technology, IDx-DR, is the only medical device authorized by the FDA that uses AI for the autonomous detection of diabetic retinopathy.